Myopia Profile

BIG BIG NEWS --> TWENTY LANGUAGE TRANSLATIONS OF OUR INFOGRAPHICS NOW AVAILABLE! We're excited to announce that we've reached a significant milestone in accessibility and availability of our world-leading Managing Myopia Guidelines Infographics and Managing Myopia Patient Brochure, in the Resources Centre on MyopiaProfile.com. These are entirely free to download, designed to support clinical communication and patient management through engaging imagery and simplified processes. We are enormously grateful to the following generous colleagues across the world for their efforts in supporting and verifying these translations, previously and recently. Thank you so much for your efforts in working with our outstanding Myopia Profile team member Kimberley Ngu, who has worked tirelessly on designing and managing these translations for quite a while now! HUGE credit to Kimberley! Arabic: fadi wakileh Chinese (Simplified and Traditional): Connie Gan  Czech: Ondřej Policar Dutch: Arno van der Poort French: Philippe Seira German: Alexandra Amesmann Hebrew: Oded Zvibach B.Optom EAOO  Italian: Giorgio Parisotto  Norwegian: Bjarne Lohmann Madsen Polish: Sylwia Kropacz-Sobkowiak Portuguese (Brazilian): Roseane Pavan Romanian: Daniela Goicea Slovak: Eva Valkovičová Spanish: Monica Marquez Swedish: Teresa Björkeroth Turkish: Uğur Emrah Altiparmak Ukrainian: Tetiana Baran Vietnamese: Minh Anh Tran Read more about the infographics and follow links to download here: https://lnkd.in/gS_MnBUt #myopia #myopiamanagement #myopiacontrol #professionallearning

Friday Science Time: 4-year results of Diffusion Optics Technology (DOT) spectacle lenses for myopia control Today we’re highlighting an important new paper on myopia management! This study showed that modulating retinal contrast using DOT 0.2 spectacle lenses by SightGlass Vision, Inc. safely slowed myopia progression in children, with treatment effects lasting into 4 years. The overall efficacy was strongly effected by COVID-19 lockdowns in years 2 and 3, with most of the treatment accrued in the first year. This is the first data on efficacy of myopia control spectacles in children from 6 years of age. https://lnkd.in/gMQh-AMP #myopia #myopiacontrol #myopiamanagement #professionallearning

Did you catch our detailed coverage of the 4th Asia-Pacific Myopia Management Symposium? The highly anticipated Asia-Pacific Myopia Management Symposium (APMMS) is a premier event championed by CooperVision and dedicated to advancing and showcasing expertise in myopia management. Building on the success of the 2023 APMMS event in Taiwan, the 4th APMMS 2024 took place on Sunday October 27 in Seoul, Korea. Our latest Myopia Profile Digest takes you through the highlights! From paradigm shifts in understanding myopia, to gold standards in myopia interventions, and the future of myopia management, we’ve got it all covered! All posts about the symposium are hashtagged #APMMS2024, or you can click on the links in the newsletter to read the individual posts. Check out the newsletter here: https://lnkd.in/gnNigXZ8 PS. Subscribe to Myopia Profile Digest and check all previous themed learning editions through the footer of any page on myopiaprofile.com! #myopia #myopiacontrol #myopiamanagement #professionallearning

FRIDAY SCIENCE TIME: When is a malingerer not a malingerer? A case study report This case report demonstrates the clinical approach necessary when presenting factors and clinical findings do not align. A nuanced and holistic approach is often necessary to differentiate between a child who is malingering and those with vision function loss from other causes, which in this case was Streff syndrome. Author: Madeline Baker https://lnkd.in/gdTgVqKN #myopia #myopiacontrol #myopiamanagement #professionallearning

Boosting orthokeratology efficacy with repeated low-level red light Children wearing ortho-K lenses experiencing at least 0.50mm of axial elongation over a year received RLRL therapy as an additional treatment alongside ortho-k wear. After 1 year of combination treatment, axial length growth was slower than ortho-k wear alone, with no adverse effects. Further studies are needed to assess long-term efficacy, the underlying mechanisms and establish a full safety profile for combining RLRL with orthokeratology. https://lnkd.in/gvkKscAY This new article is a part of our latest content release which hit your inboxes last Tuesday, exploring interventions, examinations and combination treatments. All of the content is also available on MyopiaProfile.com. Make sure to subscribe to Myopia Profile Digest and check all previous themed learning editions through the footer of any page on myopiaprofile.com. #myopia #myopiacontrol #myopiamanagement #professionallearning

#APMMS2024 Update 12 - the final one! Our last session of the day was a panel discussing the future of myopia management, looking from the vantage of today's cutting edge. 🇦🇺 🇨🇳 🇹🇼 🇸🇬 🇰🇷 Moderated by Kate Gifford; the panelists were speakers Deng Zheng Yuan, Wei Pan, Tzu-Hsun Tsai, Wei Yan Ng 黄玮彦, Dr Li Lian Foo (符丽联), and Kyeong-Wook Lee. The highlights were as follows. • AI in Contact Lens Fitting: Deng Zheng Yuan highlighted AI’s role in achieving optimal contact lens fit, enhancing both fit and eye health. • Education in Myopia Prevention: Tzu-Hsun Tsai noted Taiwan’s myopia parent education efforts but mentioned that academic pressure can limit effectiveness in teens. • Outdoor Time Benefits: Wei Pan emphasized outdoor time as protective against myopia, with data showing teens also need outdoor exposure to benefit. • Astigmatism and Myopia Control: Kyeong-Wook Lee and Li Lian Foo shared insights on managing astigmatism in myopia treatment; both successfully using MiSight 1 day in astigmatic patients up to around 2D with good results (using best spherical refraction). Best acuity outcomes will depend on the patient. (See #APMMS2024 Update 11 for Dr Lee's experience in higher astigmats!) • AI and Precision Medicine: Wei Yan Ng and Li Lian Foo discussed AI and deep learning, helping to predict future ocular health outcomes from baseline imaging; and personalize treatment. • Practical Interventions: Wei Pan recommended tools like the WHO Eyes app for awareness (simple acuity testing) and said that outdoor scene classrooms were a cost-effective preventive measure, with the special wallpaper being relatively low cost to produce, but the labour for installation more costly. ⭐️ Conclusion: Kate Gifford encouraged practitioners to use available tools and technology now, without waiting for future advancements in myopia management, but that the future brings even more opportunity for best outcomes in patient care. After the final panel, closing remarks from Hae-Jung Paik, President of the Korean Myopia Society for KAPOS and representing Gachon University Gil Medical Centre Korea; and Erica Choi General Manager of CooperVision Korea; emphasized the important of myopia management and how it shapes the future for the children of today and future generations. WOW what an amazing conference this has been - blending the latest science with cutting edge clinical experience from leading eye care practitioners in this region, and globally. If you weren't able to join us online or in person for APMMS this year, championed by CooperVision, make sure to keep your eyes peeled for dates and info on the 2025 event! We'll make sure to bring you all the info. Hope you've enjoyed our Myopia Profile coverage and learnt a lot along the way - search all twelve of the #APMMS2024 updates to get the full experience! #myopia #myopiacontrol #myopiamanagement #professsionallearning

#APMMS2024 Update 11: a new consensus framework for contact lens myopia management and real-world MiSight 1 day experience. 🇸🇬 Dr Li Lian Foo (符丽联) from the Singapore National Eye Centre described a newly determined framework built through survey and consensus amongst expert and generalist eye care practitioners in the Asia-Pacific region. She said that this is needed as even with effective treatments, variations in clinical practice can lead to suboptimal patient outcomes, and creating a simplified, expert-approved treatment guidance can mitigate this. Key topics covered patient selection, fitting process, progression monitoring and expected outcomes, with consensus highlights as follows. 1️⃣ Children aged from 5 to 18+ years can be fit with myopia control contact lenses, subject to local regulations. Fitting and follow-up processes were covered. 2️⃣ Myopia control treatment success benchmarks are defined by no more than 0.50D or 0.20mm progression per year (9+ years) or 0.2-0.3mm (<9 years of age) 3️⃣ Treatment can be discontinued no sooner than 18 years of age, when myopia is changing by less than 0.25D or 0.10mm per year. This project involved experts from Singapore, Malaysia, Korea, Taiwan, Hong Kong and Japan. ************** 🇰🇷 Kyeong-Wook Lee from Dream Seoul Eye Clinic in Korea explained that in his clinic, his preferred myopia control methods are ortho-k (70%), MiSight 1 day (15%) and topical atropine 0.125% (15%). His ortho-k preference is based on a long history of fitting and success with this treatment. - With ortho-k (around 17,000 eyes fit since 2009), around 95% progress by -0.75D in two years requiring lens replacement. - With atropine 0.125% (502 eyes since 2021), he cited an ‘all or none’ response, with around 25% still progressing -0.75/year. This makes him prefer optical treatments. - With MiSight 1 day (504 eyes since 2021), a sub-analysis of 164 eyes in children aged 5-16 years where 57% had high myopia over -5.00D, one year of wear resulted in 89% progressing less than -0.50D. Axial length growth was 0.20mm, compared to 0.45mm typical for East Asian single-vision wearing children. Kyeong-Wook’s clinical protocol was to fit either ortho-k or MiSight 1 day for children with myopia up to 5D and astigmatism up to 2D. He compared efficacy for low and high myopes (4D being the cut-off) and found similar effectiveness for refraction and axial length. For those above 4D, or for flat corneas, he prefers MiSight 1 day (with top-up spectacles for residual astigmatism in kids with more than 2DC). For those not suitable for contact lenses or where needed to boost efficacy, he uses topical atropine. It’s fascinating to understand how our colleagues adapt and extend treatments for those outside the ‘typical’ ranges of clinical studies. #myopia #myopiacontrol #myopiamanagement #professionallearning

#APMMS2024 Update 10: parental behaviours and digitalisation in myopia management. 🇹🇼 Tzu-Hsun Tsai from National Taiwan University Hospital presented on the Influence of Parental Behavior on Myopigenic Behaviors and Risk of Myopia. Here’s an overview. 🧑🧒 Behaviors play a significant role in myopia development, with parental involvement being crucial in myopia management. 👓 A survey conducted among 3-18-year-olds showed rising myopia prevalence: 5.3% in kindergarten, 42.9% in elementary school, and 82.4% in high school. 👧🏻 Parental engagement in beneficial behaviors (like encouraging outdoor time) is highest for younger children but decreases as children age. ⚖️ There is a reciprocal effect where parents increase beneficial behaviors once a child is diagnosed with myopia. ⭐️ Dr. Tsai recommended routine eye exams as an opportunity to enhance parental awareness and encourage proactive behaviours. While parental influence may not fully counter teenage tendencies, early engagement can help reduce severe myopia in later years. ************ 🇸🇬 Wei Yan Ng 黄玮彦 from Singapore National Eye Centre presented ‘Integrating Digitalization into Myopia Control Strategy.’ 🎯 The growing focus on myopia includes more awareness, treatment options, and technology, yet better engagement and data integration are needed. ⚒️ Tools like OCULUS Myopia Master and Topcon MYAH improve clinical efficiency and assist with patient understanding, engagement, and compliance. 📊 AI and digital interfaces enhance myopia management but face challenges like data security, infrastructure issues, medico-legal ethics, and compatibility between devices. ⭐️ Digitalization holds great potential to facilitate best practice myopia control, and data collation for improved understanding, but must be implemented carefully without overpromising capabilities. #myopia #myopiacontrol #myopiamanagement #professionallearning

#APMMS2024 Update 9: AI in ortho-k plus the present and future myopia landscape in China. 🇨🇳 Zheng Yuan Deng from Tianjin Eye Hospital in China presented on The Value of an AI Orthokeratology Lens Evaluation System for Myopia Control. In the traditional ortho-k lens fitting process, complexity can make it difficult for beginners, with challenges include a wide variety of ortho-k lenses and brands, patient communication and accuracy of fitting. An AI evaluation system has several advantages: it can predict the trend of AL changes based on basic patient information, can generate simulated data for various ortho-k lens brands, accurately design personalized parameters and finally, can objectively interpret topography and predict effectiveness. The AI system was able to provide a detailed prediction of fitting and axial length growth for different ortho-k lens designs. 🇨🇳 Wei Pan from Aier Academy of Ophthalmology presented The Current and Future Landscape of the Childhood Myopia Epidemic in China—A Review. - Economic growth and the smartphone era in China over the past two decades have led to an increased myopia prevalence. - COVID-19 lockdown exacerbated myopia rates, with reduced outdoor time and increased indoor study/tutoring. - Myopia awareness and correction are low: 54.8% uncorrected, 31.1% undercorrected, only 14.1% fully corrected. - China’s top-down approach includes government-led screenings and school reforms like reducing homework and stopping excessive after-school educational pressures like ‘cram school’. - Volume-based procurement policies are aiming to make myopia treatments more affordable. - Outdoor scene classrooms, featuring painted outdoor scenery, showed promising results in reducing myopia onset for pre-myopes, but is less effective in emmetropes (without hyperopic reserve) and myopes. - Conclusion: Wei stressed the importance of proactive myopia management for significant public health benefits. #myopia #myopiacontrol #myopiamanagement #professionallearning

#APMMS2024 Update 8: Gold standards in myopia interventions, Part 3 and case studies panel discussion. 🇰🇷 Sun-Young Shin from the Department of Ophthalmology at Seoul St. Mary's Hospital, Korea presented her data on combining atropine with optical treatments. In a retrospective study which included 142 myopic children aged 7-13 years, with a spherical equivalent refraction (SER) of -1.00 to -9.00 diopters, all were initially prescribed 0.05% atropine as monotherapy, for progressive myopia over -1.00 D/year. Her clinical experience is that this tends to slow progression to 0.50D or less per year for around 85% of patients, but the remainder still progress quickly. For these patients, who showed myopia progression of more than 0.75D or 0.25mm per year were additionally prescribed MiSight® 1 day in combination with atropine 0.05%. In the subsequent year, progression slowed to 0.28D and 0.13mm change in the next year. Children with low-moderate myopia (less than 6D) had the strongest benefit, compared to high myopes of the same age. ************** 🇺🇸🇨🇳🇦🇺🇬🇧🇮🇪🇹🇼🇰🇷 The panel discussion was moderated by Maria Liu and Peter Chen, with speakers Kate Gifford, Nicola Logan, Ian Flitcroft, Tzu-Hsun Tsai and Sun-Young Shin. Four fascinating clinical cases were discussed and the audience was polled. 1️⃣ A 6 year old pre-myope showing the fastest shift in refraction and axial length just prior to myopia onset (shifting from around +1.25 to +0.50). The panel discussed visual environment, atropine and optical interventions, highlighting the need for motivated parents for success. 2️⃣ A 7 year old patient reporting good compliance but showing poor outcomes with 0.02% atropine, and with severe seasonal vernal keratoconjunctivitis. The panel discussed ceasing atropine (contributing to VKC?) and the challenges of CL fitting. Maria said this patient developed a shield ulcer and was fit with MiSight 1 day as a bandage as well as for myopia - with close monitoring and seasonal low level steroids, is doing very well. 3️⃣ A 9 year old competitive dancer of around -3.50D who hates her glasses. A flat cornea could limit OK fitting, but more importantly highlights long axial length (in this case almost 25mm at age 9) and need for aggressive treatment. Fit with MiSight 1 day, she showed progression after 6 months; atropine combo was refused! The need for full-time wear was reiterated, with successful outcomes over the most recent 6 months. 4️⃣ A 7 year old patient with Austism Spectrum Disorder, moderate myopia with astigmatism, and refusal to wear glasses. A difficult case; the panel discussed various challenges for contact lens fitting or atropine. Ian Flitcroft highlighted how important myopia correction is for this child to actually see and appropriately respond to faces; this being the first priority. Maria surprised everyone by saying this patient has been successfully fit with ortho-k (!!!) and not to presume it won’t be an option!